{"result": "(\"entity\"<|>PARATIROIDES<|>GEO<|>The parathyroid glands are small endocrine glands located in the neck that regulate calcium levels in the body through the secretion of parathyroid hormone (PTH).)\n##\n(\"entity\"<|>CALCIO<|>MINERAL<|>Calcium is a mineral essential for various bodily functions, including bone health and muscle function, and its levels are regulated by parathyroid hormone.)\n##\n(\"entity\"<|>FOSFATO<|>MINERAL<|>Phosphate is a mineral that works closely with calcium in the body and is affected by the action of parathyroid hormone.)\n##\n(\"entity\"<|>HORMONA PARATIROIDEA<|>HORMONE<|>Parathyroid hormone (PTH) is a hormone produced by the parathyroid glands that regulates calcium and phosphate metabolism in the body.)\n##\n(\"relationship\"<|>PSEUDOHIPOPARATIROIDISMO<|>PARATIROIDES<|>Pseudohipoparatiroidismo is related to the dysfunction of the parathyroid glands and their hormone secretion.<|>7)\n##\n(\"relationship\"<|>PSEUDOHIPOPARATIROIDISMO<|>CALCIO<|>Pseudohipoparatiroidismo is characterized by hypocalcemia, which is a low level of calcium in the blood.<|>8)\n##\n(\"relationship\"<|>PSEUDOHIPOPARATIROIDISMO<|>FOSFATO<|>Pseudohipoparatiroidismo often leads to hyperphosphatemia, which is an elevated level of phosphate in the blood.<|>8)\n##\n(\"relationship\"<|>PSEUDOHIPOPARATIROIDISMO<|>HORMONA PARATIROIDEA<|>Pseudohipoparatiroidismo is defined by resistance to the action of parathyroid hormone (PTH).<|>9)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: quirúrgico.                                                 B. Pseudohipoparatiroidismo 1a.\n        Puede ocurrir después de la extirpación de todo el tejido paratiroideo durante una tiroidec-                                           C. Pseudohipoparatiroidismo 1b.\n        tomía y una disección cervical radical por cáncer o después de una interrupción acciden-                                               D.  Pseudohipoparatiroidismo 1c.\n        tal de la vascularización de las glándulas paratiroides. Este hipoparatiroidismo puede ser\n        transitorio, frecuentemente después de la paratiroidectomía por lesión reversible de las\n        glándulas normales restantes.\n\n\n\n380                                                                                                                                                                                                                                                                      381\n---\n                                                                                                                                                 METABOLISMO FOSFOCÁLCICO,                                         TUMORES                         7\n                                                                                                                                                                               NEUROENDOCRINOS Y MEN\n\n\n\n     COMENTARIO                                                                                                                Tabla 2. Tipos de pseudohipoparatiroidismo\n     El pseudohipoparatiroidismo, resistencia a la acción de PTH en el riñón y/o el hueso, puede                                                                      OTRA                  AMPC               AUMENTO DE\n     ser idiopático o hereditario. Se caracteriza por hipocalcemia, hiperfosfatemia y elevación                                  TIPO PHP          OHA           RESISTENCIA             URINARIO         FOSFATO URINARIO A             GS α\n     de la PTH. Hay dos tipos principales:                                                                                                                        HORMONAL               POST-PTH                  LA PTH              MUTADA\n     Tipo 1: respuesta anómala fosfatúrica y de AMPc a la PTH. Hay varios subtipos causa-                                             1a             Sí                 Sí                    No                     No                    Sí\n     dos por mutaciones de           GNAS1 ( guanine nucleotide binding protein, alpha stimulating ac-                              PPHP             Sí                 No                    Sí                      Sí                   Sí\n     tivity polypeptide 1),      un gen que codifica        la subunidad      α de la   proteína    G que se     une   al\n     receptor PTH/PTHrP. Estas mutaciones genéticas dan como resultado la incapacidad de                                              1b            No                 Raro                   No                     No                    No\n     la  proteína G     para   activar  la adenil-ciclasa tras      la unión de la PTH a         su receptor. La     ac-              1c             Sí                 Sí                    No                     No                    No\n     tivación    de la   adenil-ciclasa es      necesaria    para   la transducción       de  señales que      produce\n     la respuesta del órgano terminal a la PTH.                                                                                       2             No                  No                    Sí                     No                    No\n     •  Tipo 1a: la herencia es autosómica dominante; es necesaria la transmisión materna de                                   Gs α: subunidad α de la proteína G; OHA: osteodistrofia hereditaria de Albright; PHP: pseudohipoparatiroidismo; PPHP: pseudopseudo-\n                                                                                                                               hipoparatiroidismo.\n        la mutación. Tienen unas alteraciones conocidas como osteodistrofia hereditaria de Al-\n        bright (OHA), que incluye facies redondas, baja estatura, huesos cortos del cuarto meta-                               Referencias:\n                                                                                                                               • Carpenter T. Etiology of hypocalcemia in infants and children. Wolfsdorf JI, ed. UptoDate. Waltham, MA: UpToDate Inc.\n        carpiano, obesidad, calcificaciones subcutáneas y retraso en el desarrollo. El gen GNAS1                                 https://www.uptodate.com (acceso 10 de junio de 2019).\n        también se expresa predominantemente a partir del alelo materno en la tiroides, las gó-                                • Melmed S, Polonsky KS, Reed Larsen P, Kronenberg HM. Williams Textbook of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016.\n        nadas y la glándula hipofisaria. Como resultado, los pacientes muestran resistencia a\n        otras hormonas acopladas a la proteína G, incluida la TSH, la hormona luteinizante, la\n        hormona estimulante del folículo y la hormona liberadora de gonadotropina (GnRH).                                  12  Un paciente de 50 años presenta una PTH elevada y calcio en el límite inferior\n        – Pseudopseudohipoparatiroidismo: aquellos con mutaciones transmitidas por vía pater-                                  de la normalidad. ¿Cuál de las siguientes patologías sospecharía?\n           na tienen el fenotipo de OHA, pero con concentraciones séricas normales de calcio,                                  A. Deficiencia severa de magnesio.\n           fosfato y PTH, porque el alelo materno normal da como resultado el mantenimiento de                                 B. Déficit de vitamina D.\n           la capacidad de respuesta renal a la PTH.                                                                           C. Síndrome de DiGeorge.\n     •  Tipo 1b: tienen hipocalcemia, pero no tienen las anomalías fenotípicas de\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>PSEUDOHIPOPARATIROIDISMO<|>EVENT<|>Pseudohipoparatiroidismo is a condition characterized by resistance to the action of PTH in the kidney and/or bone, leading to hypocalcemia and hyperphosphatemia.)\n##\n(\"entity\"<|>GNAS1<|>GENE<|>GNAS1 is a gene that encodes the alpha subunit of the G protein that binds to the PTH/PTHrP receptor, mutations in this gene can cause various types of pseudohipoparatiroidismo.)\n##\n(\"entity\"<|>OSTEODISTROFIA HEREDITARIA DE ALBRIGHT<|>EVENT<|>Osteodistrofia hereditaria de Albright is a condition associated with pseudohipoparatiroidismo, characterized by round facies, short stature, and other skeletal abnormalities.)\n##\n(\"entity\"<|>TSH<|>HORMONE<|>TSH, or thyroid-stimulating hormone, is a hormone that is affected by the resistance seen in pseudohipoparatiroidismo, along with other hormones like LH and FSH.)\n##\n(\"entity\"<|>HORMONA LUTEINIZANTE<|>HORMONE<|>Luteinizing hormone (LH) is another hormone that shows resistance in patients with pseudohipoparatiroidismo due to G protein dysfunction.)\n##\n(\"entity\"<|>HORMONA ESTIMULANTE DEL FOLÍCULO<|>HORMONE<|>Follicle-stimulating hormone (FSH) is also affected in patients with pseudohipoparatiroidismo, indicating a broader impact on hormone signaling.)\n##\n(\"entity\"<|>HORMONA LIBERADORA DE GONADOTROPINA<|>HORMONE<|>Gonadotropin-releasing hormone (GnRH) is another hormone that is impacted by the resistance to PTH in pseudohipoparatiroidismo patients.)\n##\n(\"entity\"<|>PACIENTE DE 50 AÑOS<|>PERSON<|>A 50-year-old patient presenting with elevated PTH and borderline low calcium levels, potentially indicating a condition related to pseudohipoparatiroidismo.)\n##\n(\"entity\"<|>MAGNESIO<|>MINERAL<|>Magnesium is a mineral that, when deficient, can lead to symptoms that may mimic or complicate conditions like pseudohipoparatiroidismo.)\n##\n(\"entity\"<|>VITAMINA D<|>VITAMIN<|>Vitamin D is a vitamin whose deficiency can lead to similar symptoms as those seen in pseudohipoparatiroidismo.)\n##\n(\"entity\"<|>SÍNDROME DE DIGEORGE<|>EVENT<|>DiGeorge syndrome is a condition that may be suspected in patients with elevated PTH and low calcium levels, as it can affect calcium metabolism.)\n##\n(\"relationship\"<|>PSEUDOHIPOPARATIROIDISMO<|>GNAS1<|>Mutations in the GNAS1 gene are responsible for causing different types of pseudohipoparatiroidismo.<|>8)\n##\n(\"relationship\"<|>PSEUDOHIPOPARATIROIDISMO<|>OSTEODISTROFIA HEREDITARIA DE ALBRIGHT<|>Osteodistrofia hereditaria de Albright is a phenotypic manifestation associated with pseudohipoparatiroidismo.<|>7)\n##\n(\"relationship\"<|>PSEUDOHIPOPARATIROIDISMO<|>TSH<|>Patients with pseudohipoparatiroidismo show resistance to TSH due to G protein dysfunction.<|>6)\n##\n(\"relationship\"<|>PSEUDOHIPOPARATIROIDISMO<|>HORMONA LUTEINIZANTE<|>Resistance to luteinizing hormone is observed in patients with pseudohipoparatiroidismo.<|>6)\n##\n(\"relationship\"<|>PSEUDOHIPOPARATIROIDISMO<|>HORMONA ESTIMULANTE DEL FOLÍCULO<|>Resistance to follicle-stimulating hormone is also noted in pseudohipoparatiroidismo patients.<|>6)\n##\n(\"relationship\"<|>PSEUDOHIPOPARATIROIDISMO<|>HORMONA LIBERADORA DE GONADOTROPINA<|>Gonadotropin-releasing hormone resistance is a characteristic of pseudohipoparatiroidismo.<|>6)\n##\n(\"relationship\"<|>PACIENTE DE 50 AÑOS<|>PSEUDOHIPOPARATIROIDISMO<|>The 50-year-old patient exhibits symptoms that may indicate pseudohipoparatiroidismo due to elevated PTH and low calcium levels.<|>7)\n##\n(\"relationship\"<|>PACIENTE DE 50 AÑOS<|>MAGNESIO<|>Magnesium deficiency could be a differential diagnosis for the symptoms presented by the 50-year-old patient.<|>4)\n##\n(\"relationship\"<|>PACIENTE DE 50 AÑOS<|>VITAMINA D<|>Vitamin D deficiency may also be considered in the context of the patient's symptoms.<|>4)\n##\n(\"relationship\"<|>PACIENTE DE 50 AÑOS<|>SÍNDROME DE DIGEORGE<|>DiGeorge syndrome may be suspected in the patient due to the presentation of elevated PTH and low calcium levels.<|>5)\n<|COMPLETE|>"}]}